This trial investigated the efficacy of omega-3 polyunsaturated fatty acid (n-3 PUFA)
treatment for improving depressive symptoms and cognitive performance in patients with …

Objective Subtle cognitive deficits indicating early neural risk are common in the clinical
presentation of coronary artery disease (CAD). Although deterioration may be mitigated by …

Background: Early subtle deficits in verbal memory, which may indicate early neural risk, are
common in patients with coronary artery disease (CAD). While exercise can improve …

Background Neurofilament Light Chain (NfL) is a biomarker of axonal injury elevated in mild
cognitive impairment (MCI) and Alzheimer's disease dementia. Blood NfL also inversely …

Background Cognitive function is a significant determinant of overall quality of life in patients
with coronary artery disease. Medications prescribed to control vascular risk factors often …

Background Coronary artery disease (CAD) is associated with verbal memory decline,
although deterioration may be mitigated in individuals undertaking exercise interventions …

Background Lower serum concentrations of the osteoblast-derived protein, osteocalcin,
have been associated with poorer glycemic control, insulin resistance and atherosclerosis …

Background Exercise is a promising strategy to prevent dementia, but no clinically
supervised exercise program is widely available to people with mild cognitive impairment …

Purpose Physical activity is associated with positive effects on the brain but there is a paucity
of clinical neuroimaging data in patients with coronary artery disease (CAD), a …

Background: Coronary artery disease (CAD) increases risk for vascular cognitive impairment-
no dementia (VCIND), a precursor to dementia, potentially through persistent oxidative …